IV bag

Amongst eligible patients, age and comorbidity do not predict for dose limiting toxicity from phase I chemotherapy

Amongst eligible patients, age and comorbidity do not predict for dose limiting toxicity from phase I chemotherapy

Dr. Noelle LoConte et al. sought to identify clinical and non-clinical factors which were associated with the development of dose-limiting toxicity in phase I studies. Over 200 charts were reviewed from 24 cytotoxic chemotherapy studies and Cumulative Illness Rating Score-Geriatrics (CIRS-G) score was not associated with dose-limiting toxicity. Several social and clinical factors may predict for development of dose-limiting toxicity.

Read the article


Back to Publications list